In fact, activity of the antioxidant enzymes SOD and Gpx increases in patients with NAFLD (Figure 2, Figure 3, Figure 4 and Figure 5) [232]. Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.